Abstract
In general, from this double blind study of 204 infants it appeared that prenatal oral administration of vitamin K 1 exerted a beneficial effect on the relative deficiency of prothrombin that normally exists in the newborn infant. There was no evidence of undesirable side effects from doses of vitamin K 1 employed in this study. Bilirubin levels in the newborn infants receiving vitamin K 1 were not increased over the values in the placebo group. It is not possible to conclude from these data that such treatment is to be generally endorsed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
